戻る Agenda
Multi-stakeholder Collaborations to Drive Adoption and Alignment in the Implementation of Telemedicine Platforms and the Use of Digital Measures
Session Chair(s)
Scott Askin, MSc
Global Program Regulatory Director
Novartis Pharma AG, Switzerland
This innovation session will look at ecosystems to support digital technologies modernizing clinical trials. It will present the Digital Endpoints Ecosystem and Protocols (DEEP) initiative, a collaborative initiative to define protocols and a collaboration framework for the development and implementation of digital endpoints in clinical and real-world studies. In addition, the session will propose how we can bring to scale the implementation of telemedicine platforms by complementing the trial site model with telemedicine providers and consider how these services could be used to supplement trial site operations for study visits and real time patient monitoring.
Speaker(s)
Panelist
Bryan McDowell, MBA, MSc
Clario, Switzerland
Vice President, eCOA Clinical Science and Consulting
Panelist
Kai Langel
Janssen, Spain
Senior Director, Strategy and Innovation, Global Regulatory Policy
Panelist
Alison Bond, PhD
Amgen, United Kingdom
Director, Global Regulatory and R&D Policy
Panelist
Francesca Cerreta, PharmD, MPharm, MS
European Medicines Agency, Netherlands
Principal Scientific Officer
Panelist
Julian Isla, MS
Foundation 29, Spain
Director